Characterization of the Molecular Mechanism of the Bone-Anabolic Activity of Carfilzomib in Multiple Myeloma

Carfilzomib, the next generation of proteasome inhibitor, may increase osteoblast-related markers in patients with multiple myeloma, but the molecular mechanism of its effect on mesenchymal stem cell differentiation to osteoblasts remains unknown. Herein, we demonstrated that carfilzomib significant...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Hu, Bo, Chen, Yu, Usmani, Saad Z., Ye, Shiqiao, Qiang, Wei, Papanikolaou, Xenofon, Heuck, Christoph J., Yaccoby, Shmuel, Williams, Bart O., Van Rhee, Frits, Barlogie, Bart, Epstein, Joshua, Qiang, Ya-Wei
Formato: Artigo
Idioma:Inglês
Publicado em: Public Library of Science 2013
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3774816/
https://ncbi.nlm.nih.gov/pubmed/24066119
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0074191
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados